Cargando…
Successful Use of Tofacitinib in Refractory Takayasu Arteritis: A Case Series
OBJECTIVE: To study the clinical effectiveness and safety of Tofacitinib in refractory Takayasu arteritis (TAK). METHODS: This study was conducted from September 2021 to June 2022. Ten cases of refractory TAK patients were enrolled. TAK patients who required >7.5mg prednisolone or equivalent per...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628870/ https://www.ncbi.nlm.nih.gov/pubmed/37941853 http://dx.doi.org/10.31138/mjr.230929.su |